Dixon Mitchell Investment Counsel Inc.

Position in AZN — Astrazeneca PLC

CIK 1993485 VANCOUVER, A1

Position in AZN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$152,454

-$85,393 QoQ

Shares Held

804

-33.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,212

of 1,459 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Dixon Mitchell Investment Counsel Inc. holds $10,901,778 across 3 Drug Manufacturers - General names. AZN ranks #3 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	66,500	$10,421,880
2	LLY	ELI LILLY & Co	273	$327,444
3	AZN	Astrazeneca PLC This page	804	$152,454

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$152,454	804	-33.3%	Shares	Sole	2026-08-13
2026-03-31	$237,847	1,206	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.